"CHI's Protein Biomarkers 2003 was a highlight of the year for Bayer--the visibility and networking opportunities were unparalleled."
--Marcia Lewis, Director, Genomics and Bioinformatics, Bayer Diagnostics

"This was not a basic review meeting. Real leaders discussed real issues."
--Stephen Williams, Executive Director and Worldwide Head of Clinical Technology, Pfizer Inc.

"A comprehensive synthesis of where the field of protein biomarkers is today and a good predictor of where it is headed."
--Federico Goodsaid, R&D Fellow, Schering-Plough Research Institute

"As usual, CHI anticipated emerging aspects of proteomics and biomarkers in scheduling this meeting, recruiting speakers, and attracting excellent and active participants."
--Gilbert Omenn, Univ. of Michigan

"Great Knowledge Showcase... CHI's Protein Biomarkers 2003 provided a great forum for face-to-face meetings between the users and the providers of proteomics technologies. The meeting presented new ideas for discovery and development of innovative biomarkers of diseases, drug efficacy, and toxicity, as well as opportunities for future research collaborations."
--Rakesh Dixit, Senior Research Scientist, Safety Assessment, Merck & Co., Inc.

"The quality of attendees at CHI's Protein Biomarkers 2003 meeting was significantly higher than previous meetings I have attended. I had face-to-face meetings with two global heads of biomarker development at big pharma, saving time on making separate trips."
--Stephen Kingsmore, Chief Operating Officer, Molecular Staging, Inc.

"The CHI Protein Biomarker Conference will turn out to be a defining moment in biomarker scientific development. Many of the thought leaders gathered to provide an outstanding survey of the landscape, as well as set course on where this exciting but somewhat amorphous field will head in the future."
--Stephen Naylor, Scientific Advisor, Beyond Genomics; and Professor of Genetics and Genomics, Boston University School of Medicine

"CHI captured the momentum of the industry and the interest toward increasing use of biomarkers in all phases of drug development, and indeed contributed to it by gathering relevant stakeholders."
-- Clarissa Desjardins, Executive VP, Caprion Pharmaceuticals

"Protein Biomarkers 2003 was a great opportunity for people to get together that normally don’t get to speak to each other. Large and small companies, start-ups and well established companies, research, regulatory, pharma and diagnostics... all had a chance to exchange views and opinions."
--Ursula Klause, Manager, Roche Diagnostics

"With the completion of human genome, a new frontier of proteomic has captivated researchers and health care providers alike for its potential applications in diagnosis, prevention and treatment of cancer. CHI's Protein Biomarkers 2003 meeting helped bring basic and clinical scientists, and industrial leaders together to brainstorm the promises and challenges to accelerate the discovery, development and delivery of this important discipline to the bedside."
-- Sudhir Srivastava

"I enjoyed attending CHI's Protein Biomarkers 2003 since it was well-organized with great speakers and thought-provoking topics."
-- Mohan Bangalore, Principal Scientist, Clinical Pharmacology & Discovery Medicine, GlaxoSmithKline

"This meeting marked a real maturation in the development of the field. CHI brought together many of the players and disciplines needed to build a new branch of the industry, and so initiated a very important dialog."
--Richard Barker, President, New Medicine Partners

"I felt being part of a wave which will change the pharmaceutical industry profoundly. CHI’s Protein Biomarkers conference being the ultimate trigger."
-- Koen Kas, Business Development Manager, VIB Flanders Interuniv Institute for Biotech

"The Protein Biomarkers 2003 was very well organized. It provided excellent opportunities for networking and learning about the most recent developments in the field."
--Peter Tunon, VP Business Development, Expression Pathology Inc.

"It was nice to meet a mix of representatives from different backgrounds..."
-- Riet Hilhorst , PamGene BV

"...informative, inspiring, and intoxicating..."
--Joel Pounds, Pacific Northwest National Lab

"Focused, relevant, and timely... The only way to learn from and speak to the leaders in the field."
--Brian Balgley, Calibrant Biosystems

"Protein Biomarkers 2003 brought together academy and industry with amazing synergy. A ‘must attend’ for everybody in the area of biomarker discovery all the way to the clinic."
--Elzbieta Izbicka, Head, Molecular Targets and Tumor Cell Biology, Institute for Drug Development

"Very informative and helpful in bridging the gap in biomarker discovery and development by bringing all aspects and people together."
--Meeta Patnaik, VP Clinical Diagnostics, Pathway Diagnostics

Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, Ma 02464
Phone: 781-972-5400
Fax:  781-972-5425
Email: chi@healthtech.com